147 related articles for article (PubMed ID: 27164531)
1. Prevalence of Endocrinopathies in Turkish Children With β-Thalassemia Major: A Single-Center Study.
Altincik A; Akin M
J Pediatr Hematol Oncol; 2016 Jul; 38(5):389-93. PubMed ID: 27164531
[TBL] [Abstract][Full Text] [Related]
2. Endocrinopathies in Turkish children with Beta thalassemia major: results from a single center study.
Isik P; Yarali N; Tavil B; Demirel F; Karacam GB; Sac RU; Fettah A; Ozkasap S; Kara A; Tunc B
Pediatr Hematol Oncol; 2014 Oct; 31(7):607-15. PubMed ID: 24854890
[TBL] [Abstract][Full Text] [Related]
3. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
[TBL] [Abstract][Full Text] [Related]
4. Endocrinopathies in beta-thalassemia major. Prevalence, risk factors, and age at diagnosis in Northwest Saudi Arabia.
Habeb AM; Al-Hawsawi ZM; Morsy MM; Al-Harbi AM; Osilan AS; Al-Magamsi MS; Zolaly MA
Saudi Med J; 2013 Jan; 34(1):67-73. PubMed ID: 23299162
[TBL] [Abstract][Full Text] [Related]
5. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
6. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
[TBL] [Abstract][Full Text] [Related]
7. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases.
Clin Endocrinol (Oxf); 1995 Jun; 42(6):581-6. PubMed ID: 7634497
[TBL] [Abstract][Full Text] [Related]
8. Detection of endocrine disorders in young children with multi-transfused thalassemia major.
Mahmoud RA; Khodeary A; Farhan MS
Ital J Pediatr; 2021 Jul; 47(1):165. PubMed ID: 34332621
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
De Sanctis V; Eleftheriou A; Malaventura C;
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
Moayeri H; Oloomi Z
Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
[TBL] [Abstract][Full Text] [Related]
11. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.
Sharma R; Seth A; Chandra J; Gohain S; Kapoor S; Singh P; Pemde H
Paediatr Int Child Health; 2016 Feb; 36(1):22-7. PubMed ID: 25311879
[TBL] [Abstract][Full Text] [Related]
12. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
13. Children with hemoglobin E/β-thalassemia have a high risk of being vitamin D deficient even if they get abundant sun exposure: a study from Thailand.
Nakavachara P; Viprakasit V
Pediatr Blood Cancer; 2013 Oct; 60(10):1683-8. PubMed ID: 23733667
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.
Bordbar M; Bozorgi H; Saki F; Haghpanah S; Karimi M; Bazrafshan A; Zekavat OR
J Endocrinol Invest; 2019 Dec; 42(12):1467-1476. PubMed ID: 31228105
[TBL] [Abstract][Full Text] [Related]
15. Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis.
He LN; Chen W; Yang Y; Xie YJ; Xiong ZY; Chen DY; Lu D; Liu NQ; Yang YH; Sun XF
Biomed Res Int; 2019; 2019():6573497. PubMed ID: 31119181
[TBL] [Abstract][Full Text] [Related]
16. Unbalanced bone turnover in children with beta-thalassemia.
Salama OS; Al-Tonbary YA; Shahin RA; Eldeen OA
Hematology; 2006 Jun; 11(3):197-202. PubMed ID: 17325962
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.
Albu A; Barbu CG; Antonie L; Vladareanu F; Fica S
Postgrad Med; 2014 Sep; 126(5):121-7. PubMed ID: 25295656
[TBL] [Abstract][Full Text] [Related]
18. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).
Rafsanjani KA; Mafi N; Tafreshi RI
Pediatr Hematol Oncol; 2011 Sep; 28(6):497-508. PubMed ID: 21728720
[TBL] [Abstract][Full Text] [Related]
19. Endocrinal Complications in Children and Adolescents with Thalassemia Major in Central India: An Observational Study.
Dixit N; Shaw CK; Varshney GA; Kumar R; Saini PA; Verma P
Indian J Pediatr; 2022 Oct; 89(10):983-988. PubMed ID: 34480715
[TBL] [Abstract][Full Text] [Related]
20. Growth and endocrinopathies among children with β-Thalassemia major treated at Dubai Thalassemia centre.
Almahmoud R; Hussein A; Khaja FA; Soliman AF; Dewedar H; Shareef ZA; Mathai S
BMC Pediatr; 2024 Apr; 24(1):244. PubMed ID: 38580952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
